Soluble prorenin receptor in chronic heart failure patients

被引：0
|
作者：
Obradovic, D. [1 ]
Loncar, G. [2 ]
Trippel, T. [1 ]
Sekularac, N. [2 ]
Tahirovic, E. [1 ]
Wachter, R. [3 ]
Lainscak, M. [4 ]
Haverkamp, W. [1 ]
Dechend, R. [5 ]
Duengen, H-D [1 ]
机构：
[1] Charite Campus Virchow Klinikum CVK, Berlin, Germany
[2] Clin Hosp Ctr Zvezdara, Dept Cardiol, Belgrade, Serbia
[3] Univ Gottingen, Dept Cardiol, D-37073 Gottingen, Germany
[4] Univ Clin Resp & Allerg Dis Golnik, Dept Cardiol, Golnik, Slovenia
[5] Charite, D-13353 Berlin, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2013年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [31] Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure
    Feng, QP
    Lambert, ML
    Callow, ID
    Arnold, JMO
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (03) : 292 - 298
  • [32] Prognostic value of renin and prorenin in heart failure patients with decreased kidney function
    Szymanski, Mariusz K.
    Damman, Kevin
    van Veldhuisen, Dirk J.
    van Gilst, Wiek H.
    Hillege, Hans L.
    de Boer, Rudolf A.
    AMERICAN HEART JOURNAL, 2011, 162 (03) : 487 - 493
  • [33] Soluble vascular endothelial growth factor receptor-2 serves as a predictor of cardiovascular events in patients with chronic heart failure
    Iguchi, M.
    Wada, H.
    Akao, M.
    Ura, S.
    Masunaga, N.
    Ishii, M.
    Unoki, T.
    Abe, M.
    Shimatsu, A.
    Hasegawa, K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 778 - 779
  • [34] Echocardiographic correlates of circulating apoptosis receptor soluble forms in patients with congestive heart failure
    Parissis, J
    Adamopoulos, S
    Venetsanou, K
    Mentzikof, D
    Kalantzi, M
    Merkouris, K
    Karas, S
    Kremastinos, D
    EUROPEAN HEART JOURNAL, 2000, 21 : 663 - 663
  • [35] Comment on: Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients With Heart Failure
    Qadeer, Ahsan
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (12)
  • [36] Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
    Tereshchenko, S. N.
    Zhirov, I. V.
    Osmolovskaya, Yu F.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 137 - 143
  • [37] Safety of Concomitant Angiotensin Receptor Blocker Therapy in Chronic Heart Failure Patients on Conventional Heart Failure Therapy
    Atashband, Armita
    Vemuri, Srinath
    Deswal, Anita
    Aguilar, David
    Ramasubbu, Kumudha
    Pritchett, Allison
    Kar, Biswajit
    Bozkurt, Biykem
    HYPERTENSION, 2009, 54 (04) : E73 - E73
  • [38] Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure
    Ptaszynska-Kopczynska, Katarzyna
    Marcinkiewicz-Siemion, Marta
    Lisowska, Anna
    Waszkiewicz, Ewa
    Witkowski, Marcin
    Jasiewicz, Malgorzata
    Miklasz, Paula
    Jakim, Piotr
    Galar, Bogdan
    Musial, Wlodzimierz Jerzy
    Kaminski, Karol Adam
    CYTOKINE, 2016, 80 : 7 - 12
  • [39] THE PROGNOSTIC VALUE OF SOLUBLE CELLULAR ADHESION MOLECULES IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE
    Yin, Wei-Hsian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 : S11 - S11
  • [40] Increased Plasma Soluble Fractalkine in Patients with Chronic Heart Failure and Its Clinical Significance
    Ji, Cui-Ling
    Nomi, Adnan
    Li, Bin
    Shen, Cheng
    Song, Bing-Chun
    Zhang, Jin-Guo
    INTERNATIONAL HEART JOURNAL, 2019, 60 (03) : 701 - 707
12345